Uncategorized
Allergan rejects Valeant reach out, Ackman threatens suit over Salix
Allergan has received letters from J. Michael Pearson, chairman and CEO of Valeant, and William A. Ackman, CEO of Perishing Square Capital Management, in response to recent events surrounding the proposed merger between the companies.“It may be too late, but we still have an opportunity to take the temperature down and come together to see if we can begin a conversation that could lead to even more value for your stockholders, while still being the right transaction for ours,” Pearson wrote in the letter from Valeant to Allergan.